Table 2.
Changes in observed indices pre-treatment and post-treatment of 64 patients .
| Observed indices | Pre-treatment | Post-treatment | P |
|---|---|---|---|
| Hemoglobin value (g/L) | 104.77 ± 19.41 (56–144) | 118.08 ± 9.67 (105–142) | .000 |
| CA125 (U/ml) | 92.64 ± 104.45 (9.38–245.8) | 14.18 ± 8.95 (4.58–45.36) | .000 |
| Dysmenorrhea score (points) | 8.13 ± 0.75 (7–9) | 1.36 ± 0.65 (0–3) | .000 |
| Menstrual volume score (points) | 131.42 ± 13.25 (106–166) | 22.52 ± 9.18 (3–48) | .000 |
| Uterine volume (cm3) | 173.61 ± 76.49 (76.58–340.70) | 44.98 ± 16.97 (16.47–82.19) | .000 |
Hemoglobin value is for 3 months post-treatment; CA125 is for 1-month post-treatment; dysmenorrhea score and menstrual volume score are for the first menstrual period after GnRH-a injection; uterine volume is for 3 months post-treatment.